A kind of recombinant protein and its construction method and application
A recombinant protein and fibronectin technology, applied in the field of recombinant proteins, can solve the problems of poor transdermal performance of protein-polypeptide complexes, poor stability of fibronectin, limited application of protein and polypeptides, etc. Low cost, simple preparation and low effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0039] The research and development of embodiment 1 transdermal fibronectin mutant
[0040] 1. Mutant research and development ideas:
[0041] There are surfactants, thickeners, essences, polyols and other ingredients in cosmetic formulations, which will affect the stability of protein peptides in cosmetics. At the same time, cosmetics may encounter high temperature conditions during transportation and storage, which will accelerate the degradation of protein peptides.
[0042] In the present invention, after recombining the transdermal peptide and fibronectin, according to the three-dimensional structural characteristics of the recombinant protein, the sequence of the transdermal peptide fibronectin is shown in SEQ ID No. The stability of the mutation point selection effectively avoids the active site, and does not have any impact on the function of the recombinant fibronectin.
[0043] Experimental Design: Download the crystal structure file 1fnf.pdb of human fibronectin f...
Embodiment 2
[0049] Example 2 Construction of Transdermal Fibronectin Mutant Recombinant Protein Particles
[0050] In the embodiment of the present invention, the amino acid sequence of the recombinant transdermal fibronectin mutant (A-5) is shown in SEQ ID No.1, wherein ACSPPHSKSHC is a transdermal peptide sequence, which can enhance the transdermal absorption performance of the protein, GGGGS For the link between the transdermal peptide and fibronectin.
[0051] Build method:
[0052] (1) According to the position design of the relevant sequence of the commercial vector pPICZaA, the enzyme cutting sites EcoR I and SalI were selected; the DNA sequence encoding the transdermal fibronectin mutant recombinant protein is shown as SEQ ID No.2;
[0053] (2) There is a restriction endonuclease site at the 5' and 3' ends of the synthetic recombinant protein DNA sequence, corresponding to EcoR I and SalI respectively;
[0054] (3) Insert the target fragment of the recombinant protein into the r...
Embodiment 3
[0055] Example 3 Construction of Transdermal Fibronectin Mutant-Collagenase Inhibiting Peptide Recombinant Protein Particles
[0056] In the embodiment of the present invention, the transdermal fibronectin mutant-collagenase inhibitory peptide recombinant protein is the flexible end of the recombinant transdermal fibronectin mutant prepared in Example 2, which is connected to the collagenase inhibitory peptide through a connecting peptide. The amino acid sequence is shown in SEQ ID No.4.
[0057] Build method:
[0058] (1) According to the position design of the relevant sequence of the commercial vector pPICZaA, the enzyme cleavage sites EcoR I and SalI were selected; the DNA sequence encoding the transdermal peptide-fibronectin mutant-collagenase inhibitory peptide recombinant protein is shown in SEQ ID No.5;
[0059] (2) There is a restriction endonuclease site at the 5' and 3' ends of the synthetic recombinant protein DNA sequence, corresponding to EcoR I and SalI respect...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com